Oncologists pleased with new treatments for lymphoma, lung cancer, urothelial cancer

An analysis of the online conversations of more than 1,000 health care professionals worldwide through May revealed positive reactions to the approval of three key treatment options for patients with cancer.
Research by Creation Healthcare — a leading digital insights consultancy — showed that health care professionals (HCPs) were “pleased” with the approvals of several treatment options throughout the month, including those for patients with extensive-stage small cell lung cancer (SCLC), follicular and elapsed/refractory mantle cell lymphoma, and unresectable or

An analysis of the online conversations of more than 1,000 health care professionals worldwide through May revealed positive reactions to the approval of three key treatment options for patients with cancer.
Research by Creation Healthcare — a leading digital insights consultancy — showed that health care professionals (HCPs) were “pleased” with the approvals of several treatment options throughout the month, including those for patients with extensive-stage small cell lung cancer (SCLC), follicular and elapsed/refractory mantle cell lymphoma, and unresectable or